Gautam Patel, Director, 10% Owner at Amneal Pharmaceuticals, Inc. (AMRX), bought 300,000 shares at $3.88 ($1.2M) on 2020-03-02, disclosed to the SEC on 2020-03-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.88 | 32,111 | $125K | 10.6% |
| 2 | $3.88 | 32,111 | $125K | 10.6% |
| 3 | $3.94 | 117,889 | $464K | 39.4% |
| 4 | $3.94 | 117,889 | $464K | 39.4% |
| Total | $3.93 avg | 300,000 | $1.2M | 100% |
| Filing → |
| AMRX | SELL | 2025-05-06 | $69K | — | Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |